Overview and Scope
In-vitro diagnostic devices and equipment are gadgets that test human samples collected from the human body, such as tissues and blood, with the goal of using the results to help with clinical diagnosis or management.
Sizing and Forecast
The insurance (providers, brokers and re-insurers) market size has grown strongly in recent years. It will grow from <b>$8277.04 billion in 2023 to $8898.43 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. </b> The growth in the historic period can be attributed to risk management needs, regulatory requirements, population growth, catastrophic events.
The insurance (providers, brokers and re-insurers) market size is expected to see strong growth in the next few years. It will grow to <b>$11853.99 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. </b> The growth in the forecast period can be attributed to emerging risks, digital transformation, demographic changes, sustainable and esg focus, globalization and trade:. Major trends in the forecast period include usage-based insurance (ubi), insurtech innovation, parametric insurance, cyber insurance, peer-to-peer (p2p) insurance.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Segmentation & Regional Insights
The in vitro diagnostics market covered in this report is segmented –
1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment
2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
3) By Type of Expenditure: Public, Private
4) By Product: Instruments/Equipment, Disposables
<b>North America</b> was the largest region in the global in-vitro diagnostics market in 2023. <b>Asia-Pacific</b> was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp
Major Driver Impacting Market Growth
The rising popularity of self-administered test kits is expected to propel the growth of the in vitro diagnostics market going forward. Self-administered test kits refer to medical or diagnostic kits designed for individuals to use on themselves without the need for medical professionals or trained personnel to administer the test at home. The self-administered test kits enhance accessibility by enabling individuals to perform diagnostic tests at home, offering convenience and potentially increasing demand for testing, particularly for previously undiagnosed conditions. For instance, in April 2022, according to the Centers for Disease Control and Prevention, a US-based national public health agency, there was a significant increase in the use of at-home COVID-19 tests among U.S. adults aged 18 and older from the Delta-predominant period (August to December 2021) to the Omicron-predominant period (December to March 2022). The use of at-home tests among respondents who reported COVID-19-like symptoms increased from 5.7% to 20.1%. Therefore, the rising popularity of self-administered test kits will drive the growth of the in vitro diagnostics market.
Key Industry Players
Major companies operating in the in vitro diagnostics market include <b> Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.</b>
The in vitro diagnostics market report table of contents includes:
1. Executive Summary
2.In Vitro Diagnostics Market Characteristics
3.In Vitro Diagnostics Market Trends And Strategies
4.In Vitro Diagnostics Market analysis
5.In Vitro Diagnostics Market Size And Growth
6.In Vitro Diagnostics Segmentation
7.In Vitro Diagnostics Regional And Country Analysis
.
.
.
27.In Vitro Diagnostics Competitive Landscape And Company Profiles
28.In Vitro Diagnostics Key Mergers And Acquisitions
29.In Vitro Diagnostics Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Siemens Healthineers
- F. Hoffmann-La Roche AG
- Danaher Corporation
- Abbott Laboratories Inc.
- Thermo Fisher Scientific Inc.
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
